The cardiac β-adrenergic receptor. Structural similarities of β1 and β2 receptor subtypes demonstrated by photoaffinity labeling

G. L. Stiles, R. H. Strasser, T. N. Lavin, Larry Jones, M. G. Caron, R. J. Lefkowitz

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The β-adrenergic receptor photoaffinity ligand p-azido-m-[125I]iodobenzylcarazolol has been used to covalently label the β1 and β2 adrenergic receptor binding subunits present in left ventricular myocardial membranes derived from mammalian (including human) and nonmammalian species. Covalent incorporation of the photoaffinity ligand into membrane proteins was followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In the case of the human, canine, porcine, rabbit, and rat left ventricle, all of which contain predominantly or exclusively β1-adrenergic receptors, two peptides of M(r) ≃ 62,000 (major component) and M(r) ≃ 55,000 (minor component) were specifically labeled and visualized by autoradiography. Photoincorporation into these two bands could be blocked with the appropriate drugs to display a β1-adrenergic receptor pharmacological specificity. Simultaneous sodium dodecyl sulfate-polyacrylamide gel electrophoresis of samples from each species revealed that all of the M(r) = 62,000 peptides co-migrated suggesting similarity in the β1-adrenergic receptor binding subunit peptides in all of these species. The minor component M(r) ≃ 55,000 appears to be a proteolytic degradation product of the M(r) = 62,000 peptide. Its formation could be decreased by proteinase inhibitors. This suggests that the heterogeneity of the labeling pattern observed in mammalian tissues in this and previous studies may be the result of proteolytic degradation of the receptor subunit which occurs during membrane preparation. Photoaffinity labeling of frog ventricular membranes which contain predominantly β2-adrenergic receptors also revealed two peptides of M(r) ≃ 62,000 (major component) and 55,000 (minor component) with the pharmacological selectivity of a β2-adrenergic receptor. These data suggest marked similarities in the β1- and β2-adrenergic receptor binding subunits of different species and suggest that the pharmacological subtype might be determined by the detailed structure, i.e. amino acid sequence, at the ligand binding sites of the receptor peptide.

Original languageEnglish (US)
Pages (from-to)8443-8449
Number of pages7
JournalJournal of Biological Chemistry
Volume258
Issue number13
StatePublished - 1983
Externally publishedYes

Fingerprint

Adrenergic Receptors
Labeling
Myeloma Proteins
Pharmacology
Ligands
Electrophoresis
Membranes
Sodium Dodecyl Sulfate
Peptides
Polyacrylamide Gel Electrophoresis
Degradation
Peptide Receptors
Autoradiography
Anura
Heart Ventricles
Canidae
Rats
Labels
Amino Acid Sequence
Membrane Proteins

ASJC Scopus subject areas

  • Biochemistry

Cite this

The cardiac β-adrenergic receptor. Structural similarities of β1 and β2 receptor subtypes demonstrated by photoaffinity labeling. / Stiles, G. L.; Strasser, R. H.; Lavin, T. N.; Jones, Larry; Caron, M. G.; Lefkowitz, R. J.

In: Journal of Biological Chemistry, Vol. 258, No. 13, 1983, p. 8443-8449.

Research output: Contribution to journalArticle

Stiles, G. L. ; Strasser, R. H. ; Lavin, T. N. ; Jones, Larry ; Caron, M. G. ; Lefkowitz, R. J. / The cardiac β-adrenergic receptor. Structural similarities of β1 and β2 receptor subtypes demonstrated by photoaffinity labeling. In: Journal of Biological Chemistry. 1983 ; Vol. 258, No. 13. pp. 8443-8449.
@article{fce4bfcd2af8488abff37fe871b5aa37,
title = "The cardiac β-adrenergic receptor. Structural similarities of β1 and β2 receptor subtypes demonstrated by photoaffinity labeling",
abstract = "The β-adrenergic receptor photoaffinity ligand p-azido-m-[125I]iodobenzylcarazolol has been used to covalently label the β1 and β2 adrenergic receptor binding subunits present in left ventricular myocardial membranes derived from mammalian (including human) and nonmammalian species. Covalent incorporation of the photoaffinity ligand into membrane proteins was followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In the case of the human, canine, porcine, rabbit, and rat left ventricle, all of which contain predominantly or exclusively β1-adrenergic receptors, two peptides of M(r) ≃ 62,000 (major component) and M(r) ≃ 55,000 (minor component) were specifically labeled and visualized by autoradiography. Photoincorporation into these two bands could be blocked with the appropriate drugs to display a β1-adrenergic receptor pharmacological specificity. Simultaneous sodium dodecyl sulfate-polyacrylamide gel electrophoresis of samples from each species revealed that all of the M(r) = 62,000 peptides co-migrated suggesting similarity in the β1-adrenergic receptor binding subunit peptides in all of these species. The minor component M(r) ≃ 55,000 appears to be a proteolytic degradation product of the M(r) = 62,000 peptide. Its formation could be decreased by proteinase inhibitors. This suggests that the heterogeneity of the labeling pattern observed in mammalian tissues in this and previous studies may be the result of proteolytic degradation of the receptor subunit which occurs during membrane preparation. Photoaffinity labeling of frog ventricular membranes which contain predominantly β2-adrenergic receptors also revealed two peptides of M(r) ≃ 62,000 (major component) and 55,000 (minor component) with the pharmacological selectivity of a β2-adrenergic receptor. These data suggest marked similarities in the β1- and β2-adrenergic receptor binding subunits of different species and suggest that the pharmacological subtype might be determined by the detailed structure, i.e. amino acid sequence, at the ligand binding sites of the receptor peptide.",
author = "Stiles, {G. L.} and Strasser, {R. H.} and Lavin, {T. N.} and Larry Jones and Caron, {M. G.} and Lefkowitz, {R. J.}",
year = "1983",
language = "English (US)",
volume = "258",
pages = "8443--8449",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

TY - JOUR

T1 - The cardiac β-adrenergic receptor. Structural similarities of β1 and β2 receptor subtypes demonstrated by photoaffinity labeling

AU - Stiles, G. L.

AU - Strasser, R. H.

AU - Lavin, T. N.

AU - Jones, Larry

AU - Caron, M. G.

AU - Lefkowitz, R. J.

PY - 1983

Y1 - 1983

N2 - The β-adrenergic receptor photoaffinity ligand p-azido-m-[125I]iodobenzylcarazolol has been used to covalently label the β1 and β2 adrenergic receptor binding subunits present in left ventricular myocardial membranes derived from mammalian (including human) and nonmammalian species. Covalent incorporation of the photoaffinity ligand into membrane proteins was followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In the case of the human, canine, porcine, rabbit, and rat left ventricle, all of which contain predominantly or exclusively β1-adrenergic receptors, two peptides of M(r) ≃ 62,000 (major component) and M(r) ≃ 55,000 (minor component) were specifically labeled and visualized by autoradiography. Photoincorporation into these two bands could be blocked with the appropriate drugs to display a β1-adrenergic receptor pharmacological specificity. Simultaneous sodium dodecyl sulfate-polyacrylamide gel electrophoresis of samples from each species revealed that all of the M(r) = 62,000 peptides co-migrated suggesting similarity in the β1-adrenergic receptor binding subunit peptides in all of these species. The minor component M(r) ≃ 55,000 appears to be a proteolytic degradation product of the M(r) = 62,000 peptide. Its formation could be decreased by proteinase inhibitors. This suggests that the heterogeneity of the labeling pattern observed in mammalian tissues in this and previous studies may be the result of proteolytic degradation of the receptor subunit which occurs during membrane preparation. Photoaffinity labeling of frog ventricular membranes which contain predominantly β2-adrenergic receptors also revealed two peptides of M(r) ≃ 62,000 (major component) and 55,000 (minor component) with the pharmacological selectivity of a β2-adrenergic receptor. These data suggest marked similarities in the β1- and β2-adrenergic receptor binding subunits of different species and suggest that the pharmacological subtype might be determined by the detailed structure, i.e. amino acid sequence, at the ligand binding sites of the receptor peptide.

AB - The β-adrenergic receptor photoaffinity ligand p-azido-m-[125I]iodobenzylcarazolol has been used to covalently label the β1 and β2 adrenergic receptor binding subunits present in left ventricular myocardial membranes derived from mammalian (including human) and nonmammalian species. Covalent incorporation of the photoaffinity ligand into membrane proteins was followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In the case of the human, canine, porcine, rabbit, and rat left ventricle, all of which contain predominantly or exclusively β1-adrenergic receptors, two peptides of M(r) ≃ 62,000 (major component) and M(r) ≃ 55,000 (minor component) were specifically labeled and visualized by autoradiography. Photoincorporation into these two bands could be blocked with the appropriate drugs to display a β1-adrenergic receptor pharmacological specificity. Simultaneous sodium dodecyl sulfate-polyacrylamide gel electrophoresis of samples from each species revealed that all of the M(r) = 62,000 peptides co-migrated suggesting similarity in the β1-adrenergic receptor binding subunit peptides in all of these species. The minor component M(r) ≃ 55,000 appears to be a proteolytic degradation product of the M(r) = 62,000 peptide. Its formation could be decreased by proteinase inhibitors. This suggests that the heterogeneity of the labeling pattern observed in mammalian tissues in this and previous studies may be the result of proteolytic degradation of the receptor subunit which occurs during membrane preparation. Photoaffinity labeling of frog ventricular membranes which contain predominantly β2-adrenergic receptors also revealed two peptides of M(r) ≃ 62,000 (major component) and 55,000 (minor component) with the pharmacological selectivity of a β2-adrenergic receptor. These data suggest marked similarities in the β1- and β2-adrenergic receptor binding subunits of different species and suggest that the pharmacological subtype might be determined by the detailed structure, i.e. amino acid sequence, at the ligand binding sites of the receptor peptide.

UR - http://www.scopus.com/inward/record.url?scp=0020961758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020961758&partnerID=8YFLogxK

M3 - Article

C2 - 6305985

AN - SCOPUS:0020961758

VL - 258

SP - 8443

EP - 8449

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -